Drug-device Combination Products Market
Drug-device combination products market is driven by high incidence rates of chronic pain causing diseases
WILMINGTON, DELAWARE , UNITED STATES, September 15, 2023/EINPresswire.com/ — The global โ๐๐ซ๐ฎ๐ -๐๐๐ฏ๐ข๐๐ ๐๐จ๐ฆ๐๐ข๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญโ was valued at US$ 120 Bn in 2020 and is expected to reach $221 billion by 2028 at a CAGR of 7.3%, according to our new market research.
The Research Report examines the following topics: โIndustry size, share, growth, segmentation, manufacturers and developments, key trends, market drivers, restraints, regulations, distribution methods, opportunities, strategies, potential road maps, and annual forecast until 2028.โ The market research studyโs purpose is to thoroughly investigate the Healthcare industry in order to understand it and its economic potential. As a consequence, the client gets a full grasp of the industry and business from the past, present, and future perspectives, enabling them to effectively manage resources and spend money. This research has a complete table of contents, figures, tables, and charts, as well as insightful commentary.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1534
๐๐ง๐๐ซ๐๐๐ฌ๐ ๐ข๐ง ๐๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ ๐ญ๐จ ๐๐ซ๐ข๐ฏ๐ ๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ซ๐ค๐๐ญ
The rising incidence of chronic diseases such as chronic diseases and disorders, including cancer, diabetic retinopathy, cardiovascular diseases, colorectal cancer, asthma, and obesity, cardiac conditions, multiple sclerosis, etc. is a major factor expected to drive the global drug-device combination products market. Millions of people are suffering from chronic diseases across the globe. The rising geriatric population across the globe is also an important factor contributing to the market growth.
The major product types in the market include drug eluting stents, infusion pumps, photosensitizers, orthopedic combination products, wound care combination products, inhalers, transdermal patches, and others, which include intraocular implants and drug eluting beads. Growth of home-based healthcare industry and technological advancements such as development of prefilled syringes also contribute to market growth.
๐๐๐ฎ๐ง๐๐ก ๐๐ง๐ ๐๐ฉ๐ฉ๐ซ๐จ๐ฏ๐๐ฅ ๐จ๐ ๐๐จ๐ฏ๐๐ฅ ๐๐ซ๐ฎ๐ -๐๐๐ฏ๐ข๐๐ ๐๐จ๐ฆ๐๐ข๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐๐จ๐จ๐ฌ๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก
Drug-device combination products are defined as individual products comprising two regulated components, an active pharmaceutical ingredient and medical device that are chemically or physically combined to produce a single product. The drugs present in the device are either impregnated or surface coated. Such products can be designed for local as well as systemic administration of drug to the patient. Key players in the global drug-device combination products market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market during the forecast period. Recently, combination products are emerging as innovative medical products due to their contribution in advancing medical care and are, thus, projected to have a major impact in the upcoming years.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ ๐ญ๐ก๐ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ซ ๐ฏ๐ข๐ญ๐๐ฅ ๐ฎ๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐๐ข๐ง๐ ๐ฌ- https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1534
๐๐ซ๐ฎ๐ -๐๐๐ฏ๐ข๐๐ ๐๐จ๐ฆ๐๐ข๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ: ๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
Key players in the global drug-device combination products market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global drug-device combination products market. A few expansion strategies adopted by players operating in the global drug-device combination products market are:
โข In August 2020, Teva Pharmaceutical Industries Ltd. made its generic version of Mylan’s EpiPen for children available in most retail pharmacies
โข In February 2020, Flowonix Medical, Inc. received the FDA approval for its Prometra II Programmable Pump System for use with intrathecal baclofen.
The Prometra II Pump employs a pressure-driven, valve-gated delivery mechanism to deliver medication boluses into the intrathecal space.
The report on the global drug-device combination products market discusses individual strategies, followed by company profiles of manufacturers of drug-device combination products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global drug-device combination products market.
๐๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐ซ๐ฎ๐ -๐๐๐ฏ๐ข๐๐ ๐๐จ๐ฆ๐๐ข๐ง๐๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐:
Teva Pharmaceutical Industries Ltd.,AbbVie, Inc.,Abbott Laboratories,Medtronic plc,Kaleo, Inc.,SINOMED,Alcon, Inc.,Boston Scientific Corporation,Integer Holdings Corporation,Teleflex Incorporated,Bausch Health Companies, Inc.,Haselmeier GmbH,Flowonix Medical, Inc.,Others
๐๐๐ฏ๐ ๐๐ง๐ฒ ๐๐ฎ๐๐ซ๐ฒ? ๐๐ฌ๐ค ๐๐ฎ๐ซ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ฌ: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=1534
๐๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐ข๐ง๐ญ๐จ:
On the basis of the Product type
โข Drug Eluting Stents
๏ Coronary Stents
๏ Peripheral Vascular Stents
โข Infusion Pumps
๏ Implantable Infusion Pumps
๏ Ambulatory Infusion Pumps
โข Photosensitizers
โข Orthopedic Combination Products
๏ Bone Graft Implants
๏ Antibiotic Loaded Bone Cement
โข Wound Care Combination Products
โข Inhalers
๏ Metered Dose Inhalers
๏ Dry Powder Inhalers
๏ Nebulizers
โข Transdermal Patches
โข Others
๏ Intraocular Implants
๏ Drug Eluting Beads
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก-
Medical Devices Outsourcing Market to Hit USD 232.8 Bn by 2028
ePharmacy Market Revenue to Cross USD 362.8 Bn
Nikhil Sawlani
Transparency Market Research Inc.
+ +1 518-618-1030
[email protected]
Visit us on social media:
Twitter
LinkedIn
YouTube
